Meeting
2018 ASCO Annual Meeting
Landscape of osimertinib resistant mutations between the two common subtypes of EGFR 19del or L858R in NSCLC.
Authors
Yan Zhang
Geneplus-Beijing Institute, Changping District, Beijing, China
Yan Zhang , Jun Zhao , Renhua Guo , Gen Lin , Li Liu , Chenchen Zhu , Naixin Liang , Huaxia Yang , Wen xian Wang , Pingping Dai , Yan-Fang Guan , Ling Yang , Xin Yi , Xuefeng Xia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Citation
J Clin Oncol 36, 2018 (suppl; abstr 12108)
DOI
10.1200/JCO.2018.36.15_suppl.12108
Abstract #
12108
Poster Bd #
221
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.
First Author: Takehito Shukuya
Poster
2021 ASCO Annual Meeting
Incidence and heterogeneity of C797S and other EGFR resistance mutations on routine comprehensive genomic profiling (CGP).
First Author: Pasi A. Janne
Poster
2013 ASCO Annual Meeting
Clinical next generation sequencing (NGS) to reveal high frequency of alterations to guide targeted therapy in lung cancer patients.
First Author: Siraj M. Ali
Poster
2023 ASCO Annual Meeting
First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET-altered solid tumors.
First Author: Alissa Jamie Cooper